# Study of the Transmission of Anti-interferon Type 1 Alpha Autoantibodies From Mother to Child Via the Placental Barrier

> **NCT06371235** · NA · NOT_YET_RECRUITING · sponsor: **CerbaXpert** · enrollment: 250 (estimated)

## Conditions studied

- Woman Suffering From a Pathology Frequently Associated With the Presence of These Anti-autoantibodies Type-I Interferons

## Interventions

- **OTHER:** Pregiferon

## Key facts

- **NCT ID:** NCT06371235
- **Lead sponsor:** CerbaXpert
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09
- **Primary completion:** 2024-09
- **Final completion:** 2027-03
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06371235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06371235, "Study of the Transmission of Anti-interferon Type 1 Alpha Autoantibodies From Mother to Child Via the Placental Barrier". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06371235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*